R & d- medical: biomedical (basic research)

Ended Definitive Contract Awarded Last action

Contract number
HHSN272201200011C
Awardee
Awarding agency
Obligated
$3,704,172

Award facts

Contract value 100% obligated
$3,704,171.75 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Basic Research
Pricing
Firm Fixed Price
Place of performance
Silver Spring, MD 20910, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 20 -$7,583
Other Administrative Action 19 -$159,413
Other Administrative Action 18 -$76,406
Other Administrative Action 17 $144,713
Funding Only Action 16 $4,287
Other Administrative Action 15 $0
Exercise an Option 14 $750,000
Other Administrative Action 13 $0
Other Administrative Action 12 -$100,000
Exercise an Option 11 $25,000
Other Administrative Action 10 -$20,687
Exercise an Option 9 $800,000
Funding Only Action 8 $83,617
Exercise an Option 7 · Travel logistics support $700,000
Exercise an Option 6 $84,354
Other Administrative Action 5 $202,731
Other Administrative Action 4 -$202,731
Exercise an Option 3 $202,731
Exercise an Option 2 $500,000
Other Administrative Action 1 $0
Original award $773,558
Show all 21

About this award

Written by GovTribe AI ·

This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Palladian Partners, Inc., a for-profit organization specializing in health and science communications. The contract, valued at $3,704,171.75, is for research and development in the biomedical field, specifically basic research. It is a definitive, firm fixed-price contract with a completion date of April 26, 2017.

Palladian Partners, a subsidiary of the nonprofit Altarum Institute, has received numerous prime and subcontract awards from HHS agencies, including the National Institutes of Health (NIH), Food and Drug Administration (FDA), and Centers for Disease Control and Prevention (CDC), providing a wide range of communications and outreach services. This contract does not have a set-aside designation. Palladian Partners also holds several significant federal Indefinite Delivery Vehicles (IDVs), such as a $261.4 million Multiple Award Schedule contract with the General Services Administration, further positioning the company as a key provider of communications and marketing services across the federal government, particularly within the health and research sectors.

Quick answers

Who was awarded contract HHSN272201200011C?

HHSN272201200011C was awarded to Palladian Partners, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on November 18, 2011.

How much is contract HHSN272201200011C worth?

The government has obligated $3,704,172 on HHSN272201200011C.

Was contract HHSN272201200011C competed?

The extent of competition for HHSN272201200011C was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login